High Concomitant Misuse of Fentanyl in Subjects on Opioid Maintenance Treatment

References

• Becker Buxton, M., Vlahov, D., Strathdee, S. A., Des Jarlais, D. C., Morse, E. V., Ouellet, L., & Garfein, R. S. (2004). Association between injection practices and duration of injection among recently initiated injection drug users. Drug and Alcohol Dependence, 75(2), 177–183. doi:10.1016/j.drugalcdep.2004.01.014
   Google Scholar
• Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R. J., & Taylor, R. S. (2007). Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. Health Technology Assessment, 11(9). doi:10.3310/hta11090
   Google Scholar
• Dunn, K. E., Finan, P. H., Tompkins, D. A., Fingerhood, M., & Strain, E. C. (2015). Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients. Drug and Alcohol Dependence, 157, 143–149. doi:10.1016/j.drugalcdep.2015.10.018
   Google Scholar
• Eap, C. B., Buclin, T., & Baumann, P. (2002). Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clinical Pharmacokinetics, 41(14), 1153–1193. doi:10.2165/00003088-200241140-00003
   Google Scholar
• Erbas, B., & Wodarz, N. (2014). Sucht und Drogen: Fentanyl wirdzunehmendmissbraucht. Deutschen Arztebl International, 111(38), 1560–1561.
   Google Scholar
• Garcia-Portilla, M. P., Bobes-Bascaran, M. T., Bascaran, M. T., Saiz, P. A., & Bobes, J. (2014). Long term outcomes of pharmacological treatments for opioid dependence: Does methadone still lead the pack? British Journal of Clinical Pharmacology, 77(2), 272–284. doi:10.1111/bcp.12031
   Google Scholar
• Griffiths, P., Mounteney, J., Lopez, D., Zobel, F., & Gotz, W. (2012). Addiction research centres and the nurturing of creativity. Monitoring the European drug situation: the ongoing challenge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Addiction, 107(2), 254–258. doi:10.1111/j.1360-0443.2011.03369.x
   Google Scholar
• Haasen, C., Verthein, U., Degkwitz, P., Berger, J., Krausz, M., & Naber, D. (2007). Heroin-assisted treatment for opioid dependence: Randomised controlled trial. British Journal of Psychiatry, 191, 55–62. doi:10.1192/bjp.bp.106.026112
   Google Scholar
• Hahn, J. A., Page-Shafer, K., Ford, J., Paciorek, A., & Lum, P. J. (2008). Traveling young injection drug users at high risk for acquisition and transmission of viral infections. Drug and Alcohol Dependence, 93(1–2), 43–50. doi:10.1016/j.drugalcdep.2007.08.016
   Google Scholar
• Hakkinen, M., Vuori, E., & Ojanpera, I. (2014). Prescription opioid abuse based on representative postmortem toxicology. Forensic Science International, 245, 121–125. doi:10.1016/j.forsciint.2014.10.028
   Google Scholar
• Kenan, K., Mack, K., & Paulozzi, L. (2012). Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000–2010. Open Medicine, 6(2), e41–e47.
   Google Scholar
• Kleber, H. D., Weiss, R. D., Anton, R. F., Jr., George, T. P., Greenfield, S. F., Kosten, T. R., & Regier, D. (2007). Treatment of patients with substance use disorders, second edition. American Psychiatric Association. American Journal of Psychiatry, 164(4 Suppl), 5–123.
   Google Scholar
• Maas, J., Barton, G., Maskrey, V., Pinto, H., & Holland, R. (2013). Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment. Drug and Alcohol Dependence, 133(2), 494–501. doi:10.1016/j.drugalcdep.2013.07.018
   Google Scholar
• Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., & Mattick, R. P. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. Lancet, 372(9651), 1733–1745. doi:10.1016/s0140-6736(08)61311-2
   Google Scholar
• Mounteney, J., Giraudon, I., Denissov, G., & Griffiths, P. (2015). Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe. International Journal of Drug Policy, 26, 626–631. doi:10.1016/j.drugpo.2015.04.003
   Google Scholar
• Nasser, A. F., Greenwald, M. K., Vince, B., Fudala, P. J., Twumasi-Ankrah, P., Liu, Y., & Heidbreder, C. (2015). Sustained-release buprenorphine (RBP-6000) blocks the effects of opioid challenge with hydromorphone in subjects with opioid use disorder. Journal of Clinical Psychopharmacology, 36(1), 18–26. doi:10.1097/JCP.0000000000000434
   Google Scholar
• Nielsen, D. A., Ho, A., Bahl, A., Varma, P., Kellogg, S., Borg, L., & Kreek, M. J. (2012). Former heroin addicts with or without a history of cocaine dependence are more impulsive than controls. Drug and Alcohol Dependence, 124(1–2), 113–120. doi:10.1016/j.drugalcdep.2011.12.022
   Google Scholar
• Ojanpera, I., Gergov, M., Liiv, M., Riikoja, A., & Vuori, E. (2008). An epidemic of fatal 3-methylfentanyl poisoning in Estonia. International Journal of Legal Medicine, 122(5), 395–400. doi:10.1007/s00414-008-0230-x
   Google Scholar
• Ren, J., Ning, Z., Asche, C. V., Zhuang, M., Kirkness, C. S., Ye, X., & Pan, Q. (2013). Trends and predictors in methadone maintenance treatment dropout in Shanghai, China: 2005–2011. Current Medicine Research and Opinion, 29(7), 731–738. doi:10.1185/03007995.2013.796284
   Google Scholar
• Schubert, I., Ihle, P., & Sabatowski, R. (2013). Increase in opiate prescription in Germany between 2000 and 2010: A study based on insurance data. Deutsche Arzteblatt International, 110(4), 45–51. doi:10.3238/arztebl.2013.0045
   Google Scholar
• Sessler, C. N., & Varney, K. (2008). Patient-focused sedation and analgesia in the ICU. Chest, 133(2), 552–565. doi:10.1378/chest.07-2026
   Google Scholar
• Sirohi, S., Dighe, S. V., Walker, E. A., & Yoburn, B. C. (2008). The analgesic efficacy of fentanyl: Relationship to tolerance and mu-opioid receptor regulation. Pharmacology Biochemistry and Behavior, 91(1), 115–120. doi:10.1016/j.pbb.2008.06.019
   Google Scholar
• Soyka, M., Kranzler, H. R., van den Brink, W., Krystal, J., Moller, H. J., & Kasper, S. (2011). The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence. World Journal of Biological Psychiatry, 12(3), 160–187. doi:10.3109/15622975.2011.561872
   Google Scholar
• Soyka, M., Zingg, C., Koller, G., & Kuefner, H. (2008). Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study. International Journal of Neuropsychopharmacology, 11(5), 641–653. doi:10.1017/s146114570700836x
   Google Scholar
• Tuusov, J., Vals, K., Tonisson, M., Riikoja, A., Denissov, G., & Vali, M. (2013). Fatal poisoning in Estonia 2000–2009. Trends in illegal drug-related deaths. Journal Forensic and Legal Medicine, 20(1), 51–56. doi:10.1016/j.jflm.2012.04.023
   Google Scholar
• United Nations Office on Drugs and Crime. (2006). World drug report (United Nations Publication Sales No. E.06.XI.10 ISBN 92-1). Retrieved from https://www.unodc.org/pdf/WDR_2006/wdr2006_volume1.pdf.
   Google Scholar
• Wikner, B. N., Ohman, I., Selden, T., Druid, H., Brandt, L., & Kieler, H. (2014). Opioid-related mortality and filled prescriptions for buprenorphine and methadone. Drug and Alcohol Review, 33(5), 491–498. doi:10.1111/dar.12143
   Google Scholar